Skip to main content

Advertisement

Log in

STROKE

Divergent effects of lipids on stroke

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

A large study provides causal evidence of the opposing effects of plasma low-density lipoprotein (LDL) levels on ischemic and hemorrhagic stroke in a Chinese population and suggests there is a a net benefit associated with LDL lowering.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: The link between plasma LDL and stroke.

References

  1. Feigin, V. L. et al. N. Engl. J. Med. 379, 2429–2437 (2018).

    Article  Google Scholar 

  2. Sun, L et al. Nat. Med. https://doi.org/10.1038/s41591-019-0366-x (2019).

  3. Di Angelantonio, E. et al. JAMA 302, 1993–2000 (2009).

    Article  CAS  Google Scholar 

  4. Fulcher, J. et al. Lancet 385, 1397–1405 (2015).

    Article  Google Scholar 

  5. Karatasakis, A. et al. J. Am. Heart Assoc. 6, e006910 (2017).

    Article  Google Scholar 

  6. Hindy, G. et al. Stroke 49, 820–827 (2018).

    Article  CAS  Google Scholar 

  7. Wang, X., Dong, Y., Qi, X., Huang, C. & Hou, L. Stroke 44, 1833–1839 (2013).

    Article  CAS  Google Scholar 

  8. Baigent, C. et al. Lancet 376, 1670–1681 (2010).

    Article  CAS  Google Scholar 

  9. Amarenco, P. et al. N. Engl. J. Med. 355, 549–559 (2006).

    Article  CAS  Google Scholar 

  10. Elkind, M. S. et al. Cerebrovasc. Dis. 28, 266–275 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mitchell S. V. Elkind.

Ethics declarations

Competing interests

M.S.V.E. discloses receiving personal compensation for serving as an expert witness for Merck/Organon and Auxilium; honoraria for writing chapters on stroke for UpToDate; and research support but no personal compensation for a federally funded clinical trial related to stroke prevention from both the BMS-Pfizer Alliance for Eliquis and Roche; and serving as an unpaid national board member of the American Heart Association. N.S.P. has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parikh, N.S., Elkind, M.S.V. Divergent effects of lipids on stroke. Nat Med 25, 543–544 (2019). https://doi.org/10.1038/s41591-019-0413-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-019-0413-7

  • Springer Nature America, Inc.

This article is cited by

Navigation